Transdermal drug delivery device comprising an acrylic block copolymer-based adhesive
View Patent ↗High performance, low viscosity hot melt adhesives are obtained using acrylic block copolymers. The level of acrylic block copolymer in the adhesive formulation is less than 50% by weight.
1. A transdermal drug delivery device comprising an adhesive layer, a therapeutic agent and a backing layer, wherein the adhesive layer consists of an adhesive composition comprising from about 20 to about 35% by weight, based on the weight of the adhesive composition, of an acrylic block copolymer.
2. The transdermal drug delivery device of claim 1 wherein the adhesive composition comprises said therapeutic agent.
3. The transdermal drug delivery device of claim 2 wherein the therapeutic agent is a drug.
4. The transdermal drug delivery device of claim 1 further comprising a release liner.
5. The transdermal drug delivery device of claim 1 wherein the block copolymer has the formula:
-[A1]-[B]-[A2]-
wherein A1 and A2 each represents a polymer block having a glass transition temperature (Tg) of greater than about 30° C. and B represents a polymer block having a glass transition temperature of less than about 20° C.
6. The transdermal drug delivery device of claim 5 wherein polymer block B is present in amounts of at least about 50 weight % based on the weight of the total polymer.
7. The transdermal drug delivery device of claim 5 wherein polymer blocks A1 and A2 are methyl methacrylate and polymer block B is n-butyl acrylate.
8. The transdermal drug delivery device claim 1 wherein the adhesive composition comprises, based on the weight of the adhesive composition, from about 20 to about 35 wt % of an acrylic block copolymer, from about 35 to about 80 wt % of a tackifier, and from about 10 to about 45 wt % of a diluent.
9. The transdermal drug delivery device of claim 1 wherein the block copolymer is prepared by anionic polymerization.